A Scoping Review of the Classification, Diagnosis, and Management of Hepatic Adenomas
Background Hepatic adenomas (HA), or hepatocellular adenomas, are benign, solid liver lesions that develop in otherwise normal livers, often in the setting of increased estrogen levels. While considered a benign tumor, there is a risk for substantial complications such as hemorrhage and malignant transformation. We review the diagnosis, classification, and potential therapeutic management options for patients with HA. Methods A scoping narrative review was conducted based on recent literature regarding classification, diagnosis, and management of HA. Results While HAs are typically considered benign, complications such as hemorrhage and malignant transformation may occur in approximately 25% and 5% of patients, respectively. Recent advances in imaging and molecular profiling have allowed for the classification of HAs into subtypes allowing for patient risk stratification that helps guide management. Surgical resection should be considered in asymptomatic patients who are male, have an adenoma ≥5 cm in diameter, or have the β-catenin-activated subtype due to an increased risk of hemorrhage and/or malignant transformation. Conclusion Molecular profiling has aided in the stratification of patients relative to the risk of complications to predict better the potential behavior of HAs..
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:26 |
|---|---|
| Enthalten in: |
Journal of gastrointestinal surgery - 26(2022), 4 vom: 26. Jan., Seite 965-978 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Aziz, Hassan [VerfasserIn] |
|---|
| Links: |
Volltext [lizenzpflichtig] |
|---|
| Themen: |
|---|
| Anmerkungen: |
© The Society for Surgery of the Alimentary Tract 2022 |
|---|
| doi: |
10.1007/s11605-022-05246-8 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
OLC2078506311 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | OLC2078506311 | ||
| 003 | DE-627 | ||
| 005 | 20230512093244.0 | ||
| 007 | tu | ||
| 008 | 221220s2022 xx ||||| 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s11605-022-05246-8 |2 doi | |
| 035 | |a (DE-627)OLC2078506311 | ||
| 035 | |a (DE-He213)s11605-022-05246-8-p | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 610 |q VZ |
| 082 | 0 | 4 | |a 610 |q VZ |
| 100 | 1 | |a Aziz, Hassan |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a A Scoping Review of the Classification, Diagnosis, and Management of Hepatic Adenomas |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 500 | |a © The Society for Surgery of the Alimentary Tract 2022 | ||
| 520 | |a Background Hepatic adenomas (HA), or hepatocellular adenomas, are benign, solid liver lesions that develop in otherwise normal livers, often in the setting of increased estrogen levels. While considered a benign tumor, there is a risk for substantial complications such as hemorrhage and malignant transformation. We review the diagnosis, classification, and potential therapeutic management options for patients with HA. Methods A scoping narrative review was conducted based on recent literature regarding classification, diagnosis, and management of HA. Results While HAs are typically considered benign, complications such as hemorrhage and malignant transformation may occur in approximately 25% and 5% of patients, respectively. Recent advances in imaging and molecular profiling have allowed for the classification of HAs into subtypes allowing for patient risk stratification that helps guide management. Surgical resection should be considered in asymptomatic patients who are male, have an adenoma ≥5 cm in diameter, or have the β-catenin-activated subtype due to an increased risk of hemorrhage and/or malignant transformation. Conclusion Molecular profiling has aided in the stratification of patients relative to the risk of complications to predict better the potential behavior of HAs. | ||
| 650 | 4 | |a Hepatic adenoma | |
| 650 | 4 | |a Malignant transformation | |
| 650 | 4 | |a Molecular profiling | |
| 700 | 1 | |a Brown, Zachary J. |4 aut | |
| 700 | 1 | |a Eskander, Mariam F. |4 aut | |
| 700 | 1 | |a Aquina, Christopher T. |4 aut | |
| 700 | 1 | |a Baghdadi, Azarakhsh |4 aut | |
| 700 | 1 | |a Kamel, Ihab R. |4 aut | |
| 700 | 1 | |a Pawlik, Timothy M. |0 (orcid)0000-0002-4828-8096 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of gastrointestinal surgery |d Springer US, 1997 |g 26(2022), 4 vom: 26. Jan., Seite 965-978 |w (DE-627)320502201 |w (DE-600)2012365-6 |w (DE-576)091140536 |x 1091-255X |7 nnns |
| 773 | 1 | 8 | |g volume:26 |g year:2022 |g number:4 |g day:26 |g month:01 |g pages:965-978 |
| 856 | 4 | 1 | |u https://doi.org/10.1007/s11605-022-05246-8 |z lizenzpflichtig |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_OLC | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a SSG-OLC-DE-84 | ||
| 951 | |a AR | ||
| 952 | |d 26 |j 2022 |e 4 |b 26 |c 01 |h 965-978 | ||